SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
0.6501
-0.0299 (-4.40%)
At close: Aug 25, 2026, 4:00 PM EDT
0.6631
+0.0130 (2.00%)
After-hours: Aug 25, 2026, 6:50 PM EDT

SkinHealth Systems Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-28.43-9.52-29.1-100.1244.22-378.76
Depreciation & Amortization
24.3925.3533.6834.6822.8717.93
Other Amortization
43.643.324.234.234.06
Stock-Based Compensation
11.0114.8226.722.5428.512.42
Provision & Write-off of Bad Debts
1.142.075.135.151.620.85
Other Operating Activities
12.36-9.253.831.91-62.78318.03
Change in Accounts Receivable
6.265.1620.816.52-32.03-31.01
Change in Inventory
7.1715.79-10.5-22.62-84.36-7.29
Change in Accounts Payable
5.65-7.18-43.7844-2.9510.52
Change in Income Taxes
------0.56
Change in Other Net Operating Assets
-21.59-3.46.08-14.55-25.9325.45
Operating Cash Flow
21.9637.4916.1321.75-106.6-28.36
Operating Cash Flow Growth
-44.30%132.34%-25.82%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.82-0.3-0.76-22.28-12.32-11.2
Cash Acquisitions
------22.9
Sale (Purchase) of Intangibles
-4.5-4.86-6.04-9.22-6.55-4.42
Other Investing Activities
-----0.78
Investing Cash Flow
-5.32-5.16-6.79-31.51-18.87-37.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----5
Long-Term Debt Issued
-237.6---750
Total Debt Issued
-0.7237.6---755
Short-Term Debt Repaid
------5
Long-Term Debt Repaid
--410.96-156.08---225.49
Total Debt Repaid
-20.16-410.96-156.08---230.49
Net Debt Issued (Repaid)
-20.86-173.35-156.08--524.51
Issuance of Common Stock
-----188.38
Repurchase of Common Stock
-1.58-1.57-1.96-35.63-200.93-
Other Financing Activities
---0.3-1.82-4.32246.14
Financing Cash Flow
-22.45-174.93-158.34-37.45-205.24959.04

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.125.21-3.962.03-2.98-0.54
Net Cash Flow
-5.93-137.39-152.96-45.17-333.69892.4

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
21.1437.1815.38-0.53-118.92-39.56
Free Cash Flow Growth
-46.08%141.79%----
Free Cash Flow Margin
7.29%12.36%4.60%-0.13%-32.50%-15.21%
Free Cash Flow Per Share
0.170.270.11-0.00-0.80-0.39
Levered Free Cash Flow
27.4837.9731.824.91-109.5-22.77
Unlevered Free Cash Flow
39.3146.4134.9829.21-105.36-19.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
14.4414.448.019.389.8210.25
Cash Income Tax Paid
3.953.952.82.3-1.341.7
Change in Working Capital
-2.5110.37-27.3923.36-145.27-2.89
SEC Filings: 10-K · 10-Q